Ovarian Cancer
Liposomal Doxorubicin HCl Tested In Women With Recurrent Disease
Published in Cancer Weekly, August 21st, 2001
The report was published in the July 2001 issue of The Journal of Clinical Oncology. The randomized, multicenter study, evaluating 474 patients at 104 research centers in the United States and Europe, was one of the largest conducted among women suffering from ovarian cancer. The report provided the results of a Phase III clinical trial comparing Doxil and topotecan. Further studies will be required to establish the clinical benefit of Doxil.
The objective of the study was to compare the efficacy and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-08-21)
More Articles from Cancer Weekly
- Leukemia
New Gene-Targeted Therapy Promises Improved Cure Rates For AML - Skin Cancer
Discovery May Lead To First Drug Therapy - Cancer Therapies
Researchers Seek To 'Inactivate' Cancer Cells - Liver Cancer
Tumor Growth Inhibited With Endostatin Expression - Ovarian Cancer
Certain Symptoms Common in Affected Women - Prostate Cancer
PSA Levels Decline With Thalidomide Use In Metastatic Disease - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
